MedTrace Logo

Perioperative Transfusion Strategies in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery

NCT04973514 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-04-01

No results posted yet for this study

Summary

Due to better medical care, a growing number of patients with congenital heart disease reach adulthood. A large number of these patients needs a redo cardiac surgery. No guidelines of best transfusion practice exist for this patient population. A retrospective analysis of all adult patients with congenital heart disease undergoing cardiac surgery between 2000 and 2020 will be performed. Transfusion practices and their influence on outcome at 30 days and 6 month will be evaluated.

Conditions

  • Congenital Heart Disease
  • Cardiac Surgery
  • Blood Transfusion
  • Morbidity, Multiple

Interventions

PROCEDURE

Cardiac surgery in grown-up congenital heart disease patients

Analysis of patient blood management, influence on 30 day and 6 month outcome

Sponsors & Collaborators

  • Brugmann University Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-20
Primary Completion
2022-09-30
Completion
2022-12-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04973514 on ClinicalTrials.gov